Key Insights

Highlights

Success Rate

100% trial completion

Treatment Research

4 treatments under study, led by Baska Mask

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+85.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Baska Mask1
  • Blockbuster Lma1
  • Group B Proseal Laryngeal Mask Airway1
  • Group A Baska Mask Airway1

Active Sponsors

  • Cairo University1
  • Tanta University1

Related Conditions

  • Blockbuster Lma1
  • Laparoscopic Cholecystectomy1

Activity Timeline